Search

Now showing items 121-127 of 127

Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases

Nutma, E; Fancy, N; Weinert, M; Tsartsalis, S; Marzin, MC; Muirhead, RCJ; Falk, I; Breur, M; de Bruin, J; Hollaus, D;... (2023)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies

Giovannoni, G; Hawkes, CH; Lechner-Scott, J; Levy, M; Yeh, EA; Baker, D (2021)

Organic solvents and Multiple Sclerosis: the doubled risk dilemma.

Seaton, A; Baker, D; Hedstrom, AK; Alfredsson, L; Schmierer, K (2023-09-29)

BACKGROUND: Compensation for industrial disease in the UK may be obtained in two ways. A State scheme includes a list of accepted associations between occupations and diseases with evidence of a causative association. ...

Oligodendrocytes, BK channels and the preservation of myelin.

Rupnik, M; Baker, D; Selwood, DL (2021)

Oligodendrocytes wrap multiple lamellae of their membrane, myelin, around axons of the central nervous system (CNS), to improve impulse conduction. Myelin synthesis is specialised and dynamic, responsive to local neuronal ...

Oligodendrocytes, BK channels and remyelination

Rupnik, M; Baker, D; Selwood, DL

Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment

Smets, I; Reyes, S; Baker, D; Giovannoni, G (2021)

Elevated neurofilament light chain levels in progressive multiple sclerosis effectively reduced by cladribine treatment

Yildiz, O; Mao, Z; Adams, A; Dubuisson, N; Allen-Philbey, K; Giovannoni, G; Malaspina, A; Baker, D; Gnanapavan, S; Schmierer, K (2018)

1
. . .
10
11
12
13